Sign in
4

Changes in Ownership

Milestone Pharmaceuticals Inc. Filed Acc 0001771207-26-000004

Options or other derivatives

  • Chief Commercial Officer acquired 340,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Muller Lorenz Chief Commercial Officer 2026-02-02 Grant or award · Employee Stock Option (right to buy) +204,000 204,000 D
Muller Lorenz Chief Commercial Officer 2026-02-02 Grant or award · Restricted Stock Unit +136,000 136,000 D
Loading xslF345X05/form4-02042026_100201.xml…